id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1992-S-0039-0005,FDA,FDA-1992-S-0039,ORA to the Division of Dockets Management New Drug Applications and Abbreviated New Drug Applications Field Copy Memo 29 - Memorandum re FDA-1992-S-0039-0006,Supporting & Related Material,Background Material,2003-09-30T04:00:00Z,2003,9,,,2012-11-16T22:08:41Z,,0,0,0900006480528925
FDA-1992-S-0039-0006,FDA,FDA-1992-S-0039,ORA to the Division of Dockets Management New Drug Applications and Abbreviated New Drug Applications Field Copy Memo 29 - Memorandum,Supporting & Related Material,Memorandum,2003-09-30T04:00:00Z,2003,9,,,2012-11-16T22:07:21Z,,0,0,0900006480528926
FDA-1992-S-0039-0004,FDA,FDA-1992-S-0039,CDER Postmarketing Expedited and Periodic Individual Case Safety Reports including Descriptive Material Memo 28 - Memorandum,Supporting & Related Material,Memorandum,2003-09-24T04:00:00Z,2003,9,,,2012-11-16T21:12:12Z,,0,0,0900006480528924
FDA-1992-S-0039-0003,FDA,FDA-1992-S-0039,CDER Investigational New Drug Applications  New Drug Applications Abbreviated NewDrug Applications Master Files Annual Reports Promotional Material Memo 27 - Memorandum,Supporting & Related Material,Memorandum,2003-08-27T04:00:00Z,2003,8,,,2012-11-16T21:55:28Z,,0,0,0900006480528922
FDA-1992-S-0039-0002,FDA,FDA-1992-S-0039,CDER Investigational New Drug Applications  New Drug Applications Abbreviated NewDrug Applications Master Files Annual Reports Promotional Material Memo 27 - Memorandum,Supporting & Related Material,Memorandum,2003-08-27T04:00:00Z,2003,8,,,2012-11-16T21:41:36Z,,0,0,0900006480528921